Aims: This study investigates the expression patterns of BCL2 (B-cell CLL/lymphoma2) family of proteins and the extent of vascular smooth muscle cell (VSMC) apoptosis in thoracic aortic aneurysms (TAA), type-A aortic dissections (TAD), and nondilated ascending aortic samples. Methods: Aortic wall specimens were obtained from patients undergoing surgical repair for TAA (n = 24), TAD (n = 20), and normal aortic tissues from organ donors (n = 6). The expression pattern of BCL2, BCL2L1 (BCL2-like1), BAK1 (BCL2-antagonist/ killer1), and BAX (BCL2-associated X protein) proteins was investigated by immunohistochemistry. Furthermore, colocalization of alpha smooth muscle actin (ACTA2) and caspase3 (CASP3) in aortic VSMCs was analyzed by double-immunofluorescence staining. Onset of DNA fragmentation was measured by TUNEL assay. Results: Apoptotic index was significantly increased in both TAD group (31.3 ± 17.2, P < 0.001) and TAA group (21.1 ± 12.7, P = 0.001) relative to control aortas (2.0 ± 1.2). Anti-CASP3 and ACTA2 double-immunostaining confirmed apoptosis in VSMCs in TAA and TAD groups but not in controls. Proapoptotic BAX expression was significantly elevated in VSMCs of TAA patients, compared with that of controls (OR = 20; P = 0.02; 95% CI, 16-250). In contrast, antiapoptotic BCL2L1 expression was higher in controls compared with that of TAA group (OR = 11.2; P = 0.049; 95% CI, 1.0-123.9). Furthermore, BAX/BCL2 ratio was significantly increased in both TAA (1.2 ± 0.7, P < 0.001) and TAD (0.6 ± 0.4, P = 0.05) groups relative to controls (0.2 ± 0.1, P < 0.001). Conclusions: Apoptotic VSMC depletion in human TAA/TAD is associated with disturbance of the balance between proapoptotic and antiapoptotic members of the BCL2 family proteins, which may have a role in the pathogenesis of vascular remodelling in aortic disease. In light of the future studies, targeting apoptotic pathways in TAA and TAD pathogenesis may provide therapeutic benefits to patients by slowing down the progression and even possibly preventing the TAD.
Introduction
Apoptosis, as introduced by Kerr et al. [1] , is a process of noninflammatory cell death with distinctive morphological and biochemical features. It is crucial for normal development of several systems including the cardiovascular system. Vascular smooth muscle cell (VSMC) death by apoptosis has increasingly been recognized in normal physiological circumstances such as closure of ductus arteriosus and in several human vascular pathologies [2, 3] . It has been demonstrated that medial VSMC density decreases in human abdominal aortic aneurysm (AAA) tissues associated with evidence of chronic, low-level VSMC death, fragmentation of elastin, and matrix degradation [4] [5] [6] . However, neuroectodermal origin of VSMCs located in ascending aorta differs from abdominal aortic counterparts. VSMC depletion may also be involved in ascending aortic aneurysm formation, initiation of dissection, propagation, and rupture. Indeed, He et al. [7] had previously documented increased amount of apoptotic VSMCs by terminal transferase deoxyuridine triphosphate nick-end labeling (TUNEL) in the media of both thoracic aortic aneurysms (TAA) and Stanford type-A dissections (TAD).
Extensive studies regarding the molecular mechanisms of apoptosis made it clear that proteins belonging to the BCL2 (B-cell CLL/lymphoma 2) family have a critical role in regulating mitochondrion-mediated apoptosis. BCL2 family of proteins consists of both proapoptotic and antiapoptotic members that are involved in the regulation of apoptosis by forming homo/heterodimers on the outer mitochondrion membrane [8] . The relative concentrations of these proteins determine the survival or death of a cell by controlling the release of mitochondrial apoptogenic factors, cytochrome c, and apoptosis-inducing factors, which activate the downstream phases, including the activation of the caspases [9] . The ratio of antiapoptotic BCL2 family proteins (BCL2 and BCL2L1 [BCL2-like 1]) to proapoptotic members (BAX [BCL2-associated X protein], BID [BH3 interacting domain death agonist], BIK [BCL2-interacting killer; apoptosis-inducing], and BAK1 [BCL2-antagonist/killer 1]) has been shown to have a critical role in whether apoptotic cell death is initiated or the cell continues to survive [10] .
The objective of this study was to elucidate the role of BCL2 family of proteins in aortic VSMC apoptosis in TAD and TAA patients. Thus, we investigated the relevance of apoptosis together with the expression patterns of the different BCL2 family of proteins and caspase 3 (CASP3, apoptosis-related cysteine peptidase) using immunolabeling in successive sections of aorta from TAD/ TAA patients and controls. Our results may provide useful insights into the differential involvement of the BCL2 family of proteins and CASP3 in human TAA and TAD.
Methods

Aneurysmal, Dissected, and Normal Aortic Tissues
The Research Ethics Committee of the Ankara University School of Medicine approved the study protocol on February 19, 2007 February 19, (107-2808 , and all subjects gave written informed consent to participate in the study. Between May 2007 and March 2011, fullthickness ascending aortic wall specimens, which were collected from greater curvature of distal aortic root neighboring to anterolateral portion of sinotubular junction, were obtained from patients undergoing surgical repair of TAA (n = 24), or TAD (n = 20), and compared with normal aortic tissues from organ donors (n = 6). Type-A aortic dissection (TAD) was defined as any dissection that involved the ascending aorta and/or aortic arch. Particular care was taken to obtain both layers of the dissected aortic wall in the TAD group. The baseline characteristics of the patients participating in the study are summarized in Table 1 . Patients were not enrolled in the study if any one of the following exclusion criteria were met: (1) the diagnosis of Marfan syndrome (based on the revised criteria of De Paepe [11] ), Ehlers-Danlos syndrome, Loeys-Dietz syndrome, aneurysm-osteoarthritis syndrome, and familial TAA and/or dissections (caused by mutations in the alpha smooth muscle actin [ACTA2] or MYH11 gene); (2) presence of unicuspid or bicuspid aortic valve; (3) aortitis in any form or evidence for endocarditis; (4) history of cocaine abuse; and (5) iatrogenic aortic dissection or any TAD that does not involve the ascending aorta 10 mm above the sinotubular junction. Tissue samples collected at the time of operation were placed immediately into 10% neutral buffered formalin solutions, processed, and embedded in paraffin. Thickness measurements of tunica media and adventitia were performed in ACTA2-stained coverslips using LSM 510 software (Carl Zeiss, Jena, Germany) coupled to an Axiovert 100 M microscope (Carl Zeiss) with a 109 objective. The measurements considered for each vessel were the mean values of the three measurements.
Immunohistochemistry
Five-micrometer deparaffinized sections were incubated for 30 min in 0.3% hydrogen peroxide in methanol to quench endogenous peroxidase activity. Slides were washed in phosphate buffered saline (PBS) for 10 min, three times, and incubated with blocking serum (normal goat serum 1.5%, bovine serum albumin 2%, Triton X-100 0.1%) for one hour at room temperature. Primary antibodies against BCL2, BCL2L1, BAX, BAK1 ( In Situ End-Labeling of DNA Fragments (TUNEL) DNA fragmentation was detected in situ with a DNTT (terminal deoxynucleotidyl transferase)-mediated fluorescein-dUTP labeling kit (Roche Diagnostics, Mannheim, Germany) in the parallel sections according to manufacturer's instructions. To detect all nuclei, we used 7-aminoactinomycin D (7-AAD; Sigma, St Louis, MO, USA). For each aortic sample, at least 10 grid fields per section within the VSMC layer were examined with an excitation wavelength of 450-500 nm and detection wavelength of 515-565 nm. As negative control, the slides were incubated in the absence of DNTT. For positive controls, the samples were first treated with DNase I for 10 min at 20°C to induce DNA strand breaks prior to labeling procedures and then incubated with 50 lL of TUNEL reaction mixture. Two observers (K.C.A. and G.C.D.) who were unaware of the subjects' clinical profiles interpreted images independently and evaluated apoptotic indexes. Apoptotic index was calculated using the following formula: 100 9 (number of TUNEL-positive cell nuclei per field/total number of cell nuclei per field). The interobserver correlation was 2.26, whereas the intraclass correlation, obtained by a single observer who interpreted two images obtained at least 1 week apart from a single subject, was 0.94.
(Zymed Laboratories Inc.) were used as secondary antibodies, respectively. Nuclei were stained with Sytox green (1 lg/mL) in 1:1 dilution of PBS/glycerol-mounting medium. Immunofluorescent labeling results were examined on a Zeiss LSM 510 Meta confocal laser scanning microscope (Carl Zeiss) using 488-nm argon ion, 543-and 633-nm helium neon lasers; 409 Plan-Apo oil and 1009 Plan-Apo oil objectives. Single optical images were scanned with 1600 9 1600 frame size and <1.2 lm optical thicknesses. Length and area measurements and gray scale-based threshold (>50 was considered positive staining) tools in the LSM-510 software (version 3.2) were used to semiautomatically calculate the area. The detection parameters, such as laser intensity, amplifier offset and gain, and pinhole diameter, were fixed and kept at the same values for all specimens.
Statistical Analysis
Continuous variables (age, systolic blood pressure, diastolic blood pressure, aortic diameter, apoptosis index, and BAX/ BCL2 ratio) were given as mean ± standard deviation or median (interquartile range: IQR) and were compared by using Kruskal-Wallis analysis. Pairwise comparisons were made by a method that has been previously defined [13] when KruskalWallis analysis revealed that a significant difference exists. We compared ordinal variables (BCL2, BAK1, BCL2L1 and BAX) using ordinal logistic regression with proportional odds model. In this analysis, odds of having higher categories of the ordinal variables were compared with that of having lower categories. Other categorical variables were compared by chisquare test. These analyses were performed using SPSS® Statistics 18.0 (SPSS Inc, Chicago, IL, USA). ACTA2 and CASP3 areas were compared by nonparametric analysis of covariance with adjusting for age. This analysis is performed in R software [14] , and "sm.ancova" function is used under "sm" library [15] . We performed Benjamini-Hochberg procedure using "p.adjust" function to control the Type I error after pairwise comparisons [16] . A P value of 0.05 was considered significant.
Results
Clinical Characteristics and Assessment of Aortic Disease in TAA and TAD Patients Table 1 summarizes the clinical characteristics of the study cohort. Mean age for the aneurysm and dissection groups was significantly greater than control group. Range of maximum ascending aortic diameter in TAD and TAA patients assessed by computerized tomography, magnetic resonance imaging, or transesophageal echocardiography was between 36 and 70 mm (56.8 ± 8.5 mm) and 54 and 65 mm (58.6 ± 2.7 mm), respectively. Aortic diameter in control patients was between 27 and 32 mm (29.5 ± 1.8 mm). All samples in TAA group were free from intraluminal thrombus. None of the groups demonstrated evidence of aortitis observed in H&E staining. Aortic tunica media were significantly thinner in TAA (421 ± 29 lm; 95% CI, 408-433) and TAD (556 ± 32 lm; 95% CI, 541-571) compared with that of control subjects (1369 ± 24 lm; 95% CI, 1343-1394; P < 0.001) as shown in Figure 1(A) . Moreover, VSMC area through ACTA2 within aortic tunica media was significantly reduced in TAA (0.077 ± 0.008 mm 2 ) and TAD (0.074 ± 0.007 mm 2 ) compared with that of control subjects (0.185 ± 0.011 mm 2 ) as shown in Figure 1(B) . Thinning of the arterial wall, elastic fiber fragmentation along with disrupted architecture, and VSMC depletion were common in TAA and TAD groups according to confocal microscopic examination ( Figure 1A,B) . In the control group, VSMCs were arranged obliquely interconnected with the elastic laminae.
Altered Expression of BCL2 Family of Proteins
For a better understanding of molecular mechanisms of increased VSMC apoptosis in aneurysm degeneration and dissection, the expression pattern of different BCL2 family of proteins (BCL2, BCL2L1, BAX, and BAK1) was investigated by immunohistochemistry in aortic sections (Figure 2 ). The intensity of these proteins was semiquantitatively scored [12] (Table 2) . Furthermore, to assess the involvement of relevant protein expression, existence of positive immunoreactivity was evaluated. Proapoptotic BAX expression was significantly elevated in VSMCs of TAA patients, compared with that of controls (OR = 20; P = 0.02; 95% CI, 16-250). In contrast, antiapoptotic BCL2L1 expression was greater in controls compared with that of TAA group (OR = 11.2; P = 0.049; 95% CI, 1.0-123.9). TAD group also showed a similar trend to TAA group with regards to BCL2L1 expression, but the results were not statistically significant when compared to controls (OR = 7.6; P = 0.06; 95% CI, 0.9-50).
Furthermore, we investigated the ratio of BAX to BCL2 expression as previously described [17] . As the control group exhibited no immunoreactivity for proapoptotic BAX, BAX/BCL2 ratio was close to zero in the control group. BAX/BCL2 ratio was significantly increased in both TAA (1.2 ± 0.7, P < 0.001) and TAD (0.6 ± 0.4, P = 0.05) groups relative to controls (0.2 ± 0.1, P < 0.001).
TAAs and TADs Exhibit Aortic VSMC Apoptosis
All of the immunostaining and TUNEL staining were made in successive sections, which were 5 lm apart, and the majority of cell type was VSMCs in media in all groups as confirmed by ACTA2 immunostaining (Figure 2) . VSMC apoptosis was detected in 18 of 20 TAD sections (90%) and 20 of 24 TAA sections (83.3%), whereas negligible apoptosis was detected in control sections. Apoptotic index was significantly increased in both TAD group (31.3 ± 17.2, P < 0.001) and TAA group (21.1 ± 12.7, P = 0.001) relative to control aortas (2.0 ± 1.2) as shown in Figure 3 . Furthermore, TAD group demonstrated higher apoptotic index compared with TAA group (P = 0.041).
To confirm that apoptosis is restricted to VSMCs, we further performed CASP3 and ACTA2 double immunolabeling. CASP3 immunoreactivity was colocalized with ACTA2 in medial layer of TAA and TAD groups, whereas none or very little CASP3 staining was found in control group samples (Figure 4 ). CASP3 area measurement in aortic tunica media was significantly higher in Representative micrographs for immunohistochemical stainings of serial aortic paraffin sections of the 27-mm ascending aorta of a 37-year-old man from the control group (left column); 67-mm ascending aortic aneurysm of a 66-year-old man from the thoracic aortic aneurysms (TAA) group (middle column); and 70-mm aortic aneurysm after acute type-A aortic dissection of a 64-year-old man from the type-A aortic dissections (TAD) group (right column) for ACTA2, antiapoptotic (BCL2, and BCL2L1), and proapoptotic (BAX, and BAK1) proteins. Elastic fiber fragmentation along with disrupted architecture and vascular smooth muscle cell (VSMC) depletion were common in TAA and TAD groups. Scale bar is 50 lm. 
Discussion
This study has focused on VSMCs, which is a poorly explored area of the ascending aorta. We investigated whether medial VSMCs survive or resist to apoptosis during the progression of TAA and TAD. A number of previous studies have documented decreased VSMC density within the medial layer of AAA in contrast to atherosclerotic and normal human aortas and have shown evidence of VSMC apoptosis in AAAs [4] [5] [6] . VSMC apoptosis has also been documented in thoracic aortic disease including congenital aortic pathologies [18] , bicuspid aortic valve [19] , and thoracic aneurysms and dissections [7] . Our study confirms VSMC depletion and an increase in the amount of apoptotic cells by TUNEL staining in the media of both TAA and TAD patients. Furthermore, the novel contribution of the present study is the evaluation of the role of BCL2 family of proteins in apoptotic VSMC depletion in the human ascending aortas. Results presented in this study suggest that TAA and TAD have similar expression patterns for BCL2 family of proteins by potentiating proapoptotic members and minimizing antiapoptotic BCL2 proteins. In brief, apoptotic VSMC depletion in TAD and TAA is associated with increased BAX/BCL2 ratios.
Erdheim's cystic medial degeneration is an important histological sine qua non of TAAs and TADs, which is also detected, in congenital aortic disease such as Marfan syndrome, atherosclerosis, and aging [20] . mRNA expression studies revealed that TAAs were associated with pronounced increases in the expression of genes involved in regulating cell survival, proliferation, and programmed cell death including TNF-a and interleukin-1b, which are potent inducers of apoptosis [21] . Wang et al. [22] had demonstrated increased expression of connective tissue growth factor and collagen deposition in the aortic wall of TAD patients. A number of causes may lead to the generation of apoptotic signals within the VSMCs, thereby impairing the maintenance of the arterial extracellular matrix and influencing the progression of aneurysms. With prolonged vessel wall stress and destructive proteases, the aorta undergoes a cascade of compensatory structural events.
Several factors may have contributed to the apoptotic signals and the expression pattern of BCL2 family of proteins in this study. Hypertension is the most consistent predisposing condition for TAAs and TADs. The reported incidence of hypertension in acute dissections is about 75% [23] . In the present study, the incidence of history of hypertension was 71% for TAA and 70% for TAD groups. Reactive oxygen species, nitric oxide, angiotensin type 2 receptors, and the endothelin system may play a role in the progression of hypertension and apoptosis of VSMCs [24] . Spontaneously, hypertensive [25] and angiotensin-infused rats [26] were found to have apoptosis detectable by DNA laddering, augmented in situ end-labeling of fragmented DNA, and/or BAX/BCL2 ratio. It has also been confirmed by Nagashima et al. [27] that angiotensin II type 2 receptor-mediated VSMC apoptosis had a pivotal role in patients with cystic medial degeneration. Detection of VSMC apoptosis in both TAA and TAD sections may also be related to other common predisposing factors such as flow and shear stress. For instance, recently Della et al. [28] demonstrated VSMC apoptosis with bicuspid aortic valve stenosis occurring prior to overt aortic dilation, mainly at the convexity, where wall stress is expectedly higher. As apoptosis is under control of complex cellular signalling pathways that are involved in responses to cellular stress signals and tissue injury, enhanced mechanical forces on medial VSMCs leading to stretch mediated reactions including programmed cell death via BAX upregulation [29] . However, we also determined an overall upregulation of antiapoptotic proteins BCL2 and BCL2L1 together with increased expression of BAX and BAK1.
According to our study design, the correlation between the stages of aortic wall expansion and initiation of BCL2 family of protein expression remains unclear. In this context, Bauriedel et al. [30] demonstrated the upregulation of BCL2 proteins after arterial injury. A certain degree of tendency for cell proliferation and survival at molecular level may also be accounted as the features of trophic response. Previously, Tang et al. [31] demonstrated decreased expression of matrix proteins as a result of increased matrix degradation but preserved VSMC density in patients with TAA. Our study supports the concept that VSMC apoptotic pathways may have a role in decreased expression of matrix proteins by documenting the relative cell depletion in the medial layer. Indeed, in agreement with our study, recent evidence supports the role of interleukin-1b and interferon-c in the formation of TAD and TAA through the upregulation of matrix metalloproteinase-9 and the apoptosis of human media cells [32] .
Latest studies have shown that inflammatory cells, which infiltrate into vascular medial and adventitial layers, may cause apoptosis in AAA patients. Chemokine, cytokine and protease secretion from the infiltrated inflammatory cells are held as the probable cause of aneurysm pathogenesis, by leading resident vascular cells to apoptosis, which eventually cause a depletion in extracellular matrix proteins [33] . Immunohistocemical analyses of our TAA/TAD samples have shown absence or low-density CD8 + T cells, CD163 + macrophages, and tryptase + mast cells (data not shown). Thus, further research methods that focus on the detection of infiltrated inflammatory cells in samples from human ascending aorta and association of these cells with possible precursors of apoptosis would be a clinically relevant approach that could elucidate the mechanism of VSMC apoptosis in TAA and TAD patient groups. It is also important to note that VSMC apoptosis might be associated with different expression patterns of BCL2 family of proteins in patients with TAA and TAD. However, the results presented cannot be generalized to all patients with aneurysms and dissections, because patients with inherited connective tissue disorders and any form of aortitis were excluded. In addition, microarray techniques revealed different profiles of altered gene expression and high degree of molecular heterogeneity in different locations of aortic aneurysms [21] . Thus, the findings cannot be extended to AAAs in which the embryonic origin of VSMCs is mesoderm [34] . The major limitations of this study were quantification of BCL2 family of proteins with methods such as Western blot or ELISA. However, our aim in this study was to demonstrate the expression patterns of these proteins within the aortic VSMCs.
Following homogenization to isolate BCL2 proteins, it would have been impossible to claim that these proteins are in fact originated from aortic VSMCs. Additionally, lack of immunocytochemistry and TUNEL assay prior to the event of TAD or in the early stages of aneurysms are lacking, which can be accomplished, in experimental models. Surgically removed relatively advanced stage aneurysmal specimens may not reflect earlier stages of aortic aneurysms or the state of impending rupture. Finally, three main questions still remain unanswered. Does the BCL2 family of protein expression start at the early stages of aneurysmal degeneration? Does the progression of TAD and development of aortic dissection change the expression profiles? And, how BCL2 family of protein expression is modulated in TAA and TAD patients?
Conclusion
The primary significance of the observations in the present study is that apoptotic VSMC depletion in TAD and TAA is associated with upregulation of death promoting and downregulation of survival promoting BCL2 family of proteins. BAX/BCL2 ratio, an apoptotic parameter that has been shown to be critical for the fate of the cell [35] , was elevated in TAA and TAD samples compared with that of control aortas. Future research should consider targeting biological pathways including the BCL2 family of proteins in the context of apoptotic VSMC depletion in TAA or dissections. Our findings may lead to the conclusion that the apoptotic index can be used as a predictor of TAA, because we have shown that the apoptotic index in patients with TAA and TAD is higher compared with the control group. In the present study, it is established that the apoptotic cell death in VSMCs is involved in the development of the TAA and TAD. In the years to come, novel medical therapies that would target the proapoptotic cascade may benefit the TAA and TAD patients, by slowing down the progression of the pathology and even preventing the development of TAA and TAD.
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